Remuzzi G - Search Results

1

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nürnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C. Legendre CM, et al. Among authors: remuzzi g. N Engl J Med. 2013 Jun 6;368(23):2169-81. doi: 10.1056/NEJMoa1208981. N Engl J Med. 2013. PMID: 23738544 Free article. Clinical Trial.

2

A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders.

Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, Rizzoni G, Taylor CM, Van de Kar N, Zimmerhackl LB; European Paediatric Research Group for HUS. Besbas N, et al. Among authors: remuzzi g. Kidney Int. 2006 Aug;70(3):423-31. doi: 10.1038/sj.ki.5001581. Epub 2006 Jun 14. Kidney Int. 2006. PMID: 16775594 Free article. Review.

3

Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation.

Saland JM, Emre SH, Shneider BL, Benchimol C, Ames S, Bromberg JS, Remuzzi G, Strain L, Goodship TH. Saland JM, et al. Among authors: remuzzi g. Am J Transplant. 2006 Aug;6(8):1948-52. doi: 10.1111/j.1600-6143.2006.01375.x. Am J Transplant. 2006. PMID: 16889549 Free article.

4

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lämmle B. Furlan M, et al. Among authors: remuzzi g. N Engl J Med. 1998 Nov 26;339(22):1578-84. doi: 10.1056/NEJM199811263392202. N Engl J Med. 1998. PMID: 9828245 Free article.

5

[Hemolytic uremic syndrome].

Rota S, Cravedi P, Remuzzi G, Ruggenenti P. Rota S, et al. Among authors: remuzzi g. G Ital Nefrol. 2005 Nov-Dec;22 Suppl 33:S57-64. G Ital Nefrol. 2005. PMID: 16419008 Review. Italian.

6

Plasma exchange in children with hemolytic-uremic syndrome at risk of poor outcome.

Gianviti A, Perna A, Caringella A, Edefonti A, Penza R, Remuzzi G, Rizzoni G. Gianviti A, et al. Among authors: remuzzi g. Am J Kidney Dis. 1993 Aug;22(2):264-6. doi: 10.1016/s0272-6386(12)70316-5. Am J Kidney Dis. 1993. PMID: 8352251

7

Complement factor H and hemolytic uremic syndrome.

Zipfel PF, Skerka C, Caprioli J, Manuelian T, Neumann HH, Noris M, Remuzzi G. Zipfel PF, et al. Among authors: remuzzi g. Int Immunopharmacol. 2001 Mar;1(3):461-8. doi: 10.1016/s1567-5769(00)00047-3. Int Immunopharmacol. 2001. PMID: 11367530 Review.

8

Treatment of the hemolytic uremic syndrome with plasma.

Remuzzi G, Misiani R, Marchesi D, Livio M, Mecca G, de Gaetano G, Donati MD. Remuzzi G, et al. Clin Nephrol. 1979 Dec;12(6):279-84. Clin Nephrol. 1979. PMID: 393447

9

Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura.

Ruggenenti P, Noris M, Remuzzi G. Ruggenenti P, et al. Among authors: remuzzi g. Kidney Int. 2001 Sep;60(3):831-46. doi: 10.1046/j.1523-1755.2001.060003831.x. Kidney Int. 2001. PMID: 11532079 Free article. Review.

10

The role of the endothelium in hemolytic uremic syndrome.

Zoja C, Morigi M, Remuzzi G. Zoja C, et al. Among authors: remuzzi g. J Nephrol. 2001 Nov-Dec;14 Suppl 4:S58-62. J Nephrol. 2001. PMID: 11798147 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,513 results

Search Page